Abveris

Boston’s premier antibody discovery partner, and a division of Twist Bioscience.

General Information
Company Name
Abveris
Founded Year
2014
Location (Offices)
Quincy, United States +1
Founders / Decision Makers
Number of Employees
23
Industries
Biopharma, Biotechnology, Pharmaceutical
Funding Stage
-
Social Media

Abveris - Company Profile

Abveris is a leading antibody discovery partner based in Boston and operates as a division of Twist Bioscience. Established in 2014, the company specializes in in vivo antibody discovery and collaborates with top biopharmaceutical scientists across various organizations. Their efforts focus on discovering and developing antibodies for pharmaceutical and industrial applications within the Biopharma, Biotechnology, and Pharmaceutical industries. Currently, there is no public information available regarding their latest investment round or investors.

Taxonomy: Antibody Discovery, Anti-Idiotype Antibodies, Hybridoma Discovery, Antibody Therapeutics, In Vivo Discovery, Reagent Antibodies

Funding Rounds & Investors of Abveris (0)

View All

There is no investment information

Latest News of Abveris

View All

No recent news or press coverage available for Abveris.

Similar Companies to Abveris

View All
Ablexis, LLC - Similar company to Abveris
Ablexis, LLC A superior, next generation transgenic platform.
Klus Pharma Inc. - Similar company to Abveris
Klus Pharma Inc. Discovery and development of novel and safer antibody-based therapeutics.
Capralogics Inc - Similar company to Abveris
Capralogics Inc Your Leading Provider of Polyclonal Antibodies and Specialized Camelid Antibody Development!
Yumab GmbH - Similar company to Abveris
Yumab GmbH From Target to Lead
艾比玛特医药科技(上海)有限公司 - Similar company to Abveris
艾比玛特医药科技(上海)有限公司 Empowering scientists with the future of antibody innovation and discovery.